Loading organizations...
SneakPeek Investments operates as a venture capital firm focused on nurturing early-stage bio and healthcare technology companies. Its core strategy involves providing capital coupled with strategic guidance, leveraging its team's extensive industry experience. The firm actively identifies promising enterprises within the healthtech sector, fostering development from nascent stages with hands-on support.
Established in 2019 by Representative Director Kim Do-hyun, the firm originated from a foundational insight. Its leadership comprises seasoned professionals who previously founded and scaled bio ventures into global enterprises. This deep operational and strategic background underpins SneakPeek Investments’ approach, enabling it to function as a knowledgeable growth partner, not just a capital provider.
SneakPeek Investments primarily serves innovative startups across the biotechnology and broader healthcare technology landscape. The firm’s vision centers on cultivating a robust ecosystem where these promising ventures can achieve full market potential. It aims to empower portfolio companies through active collaboration, ensuring sustained development and significant impact.
SneakPeek Investments has 1 tracked investment across 1 company. The latest tracked deal is $2.9B Series B in Galux in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 9, 2026 | Galux | $2.9B Series B | — | 유안타인베스트먼트, Daily Partners, Intervest, Korea Development Bank, Korea Investment & Securities, Mirae Asset Securities, NCORE Ventures, Pathway Capital Management, SL Investment |